| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/12/2011 | WO2011054916A1 Methods and pharmaceutical composition for the treatment of atherosclerosis |
| 05/12/2011 | WO2011054894A1 Composition for treating insulin resistance |
| 05/12/2011 | WO2011054315A1 Use of cyr61 protein for preparing medicine |
| 05/12/2011 | WO2011054285A1 Melanocortin receptor agonist, preparation method and use thereof |
| 05/12/2011 | WO2011031896A3 Pi3 kinase inhibitors and uses thereof |
| 05/12/2011 | WO2011029082A8 Durable treatment with 4-aminopyridine in patients with demyelination |
| 05/12/2011 | WO2011010337A9 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 05/12/2011 | WO2011008823A3 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 05/12/2011 | WO2011008495A3 Arginase formulations and methods |
| 05/12/2011 | WO2011006084A3 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 05/12/2011 | WO2010150982A9 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 05/12/2011 | WO2010138393A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | WO2010138389A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | WO2010138387A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 05/12/2011 | WO2010030359A8 Macrocyclic hepatitis c serine protease inhibitors |
| 05/12/2011 | US20110112655 Device for regeneration of articular cartilage and other tissue |
| 05/12/2011 | US20110112284 Methods for modulating ikkalpha activity |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112040 Supercharged proteins for cell penetration |
| 05/12/2011 | US20110112039 Polysaccharides comprising carboxyl functional groups substituted via esterification by a hydrophobic alcohol |
| 05/12/2011 | US20110112038 Novel npr-b agonists |
| 05/12/2011 | US20110112037 Crystal structure |
| 05/12/2011 | US20110112036 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 05/12/2011 | US20110112035 Therapeutic use of a growth factor, metrnl |
| 05/12/2011 | US20110112034 Modulation of synaptogenesis |
| 05/12/2011 | US20110112033 Cognitive enhancement and cognitive therapy using glycyl-l-2-methylprolyl-l-glutamic acid |
| 05/12/2011 | US20110112032 Regulation of Brain Natriuretic Peptide and Catecholamines for the Treatment of Cardiovascular Diseases |
| 05/12/2011 | US20110112031 Optimized dengue virus entry inhibitory peptide (dn81) |
| 05/12/2011 | US20110112030 Methods of treating or preventing stent thrombosis |
| 05/12/2011 | US20110112029 Low viscosity compositions comprising a pegylated gla-domain containing protein |
| 05/12/2011 | US20110112028 Factor viii polymer conjugates |
| 05/12/2011 | US20110112027 Factor viii polymer conjugates |
| 05/12/2011 | US20110112026 Factor viii polymer conjugates |
| 05/12/2011 | US20110112025 Factor viii polymer conjugates |
| 05/12/2011 | US20110112024 Factor viii polymer conjugates |
| 05/12/2011 | US20110112023 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 05/12/2011 | US20110112022 Factor VIII Muteins with Reduced Immonugenicity |
| 05/12/2011 | US20110112021 Pegylated recombinant human growth hormone compounds |
| 05/12/2011 | US20110112020 MEASUREMENT OF G-PROTEIN mRNA IN THE DIAGNOSIS OF GROWTH HORMONE INSUFFICIENCY |
| 05/12/2011 | US20110112019 Method for promoting hair growth or hair regeneration by maintaining or increasing expression of cell-adhesion factor |
| 05/12/2011 | US20110112018 Method for the Treatment and/or Prophylaxis of Multiple Sclerosis, and Use of Erythropoietin for the Manufacture of a Medicament for the Intermittent and/or Intermittent Prophylaxis of Multiple Sclerosis |
| 05/12/2011 | US20110112017 Compositions, methods and uses for treating diabetes |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112014 Supplementation of propane-1,2,3-triol and water in fasting subjects |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110112010 Octanoic acid formulations and methods of treatment using the same |
| 05/12/2011 | US20110111979 Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Microarray Proteomics Platforms |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111491 Rna interference suppresion of neurodegenerative diseases and methods of use thereof |
| 05/12/2011 | US20110111464 Methods and compositions for cloning nucleic acid molecules |
| 05/12/2011 | US20110111398 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms |
| 05/12/2011 | US20110111073 Recovery of hydrophobic peptides from oils |
| 05/12/2011 | US20110111058 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | US20110111056 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 05/12/2011 | US20110111054 Bmp-7 for use in treating vascular sclerosis |
| 05/12/2011 | US20110111047 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111029 Composition for transdermal delivery of cationic active agents |
| 05/12/2011 | US20110111028 Composition and Methods For Repair of Connective Tissue |
| 05/12/2011 | US20110111023 Prevention of type 1 diabetes by administration of gliadin |
| 05/12/2011 | US20110111021 Pharmaceutical preparation |
| 05/12/2011 | US20110111012 Nanomaterial wound dressing assembly |
| 05/12/2011 | US20110111010 Method and Composition for Burned Skin |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110111003 Stable cell binding chimeric peptides |
| 05/12/2011 | US20110110988 Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound |
| 05/12/2011 | US20110110987 Agent for regenerating tympanic membrane or external auditory canal |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110983 Lactoferrin as an adjuvant in cancer vaccines |
| 05/12/2011 | US20110110976 Rift valley fever virus-like particles and their use for immunization and as test system |
| 05/12/2011 | US20110110971 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 05/12/2011 | US20110110965 Compositions that induce t cell help |
| 05/12/2011 | US20110110964 Immunogenic peptides and their use in transplantation |
| 05/12/2011 | US20110110960 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110939 Methods and compositions for the treatment and diagnosis of systemic anthrax infection |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110932 Combination treatment for ocular diseases |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110925 Compositions and Methods for the Treatment and Diagnosis of Cancer |
| 05/12/2011 | US20110110923 Fish assay for eml4 and alk fusion in lung cancer |
| 05/12/2011 | US20110110922 Wound Healing Peptides and Methods of Use Thereof |
| 05/12/2011 | US20110110921 Methods for Treating Bleeding Disorders |
| 05/12/2011 | US20110110920 Method of treating peripheral arterial disease |
| 05/12/2011 | US20110110919 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| 05/12/2011 | US20110110918 Role of (de)acetylation in counteracting protein aggregation |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110916 Methods for treating and/or preventing cardiomyopathies by erk or jnk inhibition |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/12/2011 | US20110110913 Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders |
| 05/12/2011 | US20110110911 Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases |
| 05/12/2011 | US20110110910 Proteases for Pharmaceutical Use |